Biotechnology risk | Wikipedia audio article
Channel: wikipedia tts
Date: 2019-01-28

This is an audio version of the Wikipedia Article:
https://en.wikipedia.org/wiki/Biotechnology_risk


00:01:16 1 Gain of function mutations
00:01:26 1.1 Research
00:02:19 1.1.1 Mousepox
00:02:49 1.1.2 Influenza
00:04:10 1.2 Regulation
00:05:45 2 CRISPR
00:07:07 3 See also



Listening is a more natural way of learning, when compared to reading. Written language only began at around 3200 BC, but spoken language has existed long ago.

Learning by listening is a great way to:
- increases imagination and understanding
- improves your listening skills
- improves your own spoken accent
- learn while on the move
- reduce eye strain

Now learn the vast amount of general knowledge available on Wikipedia through audio (audio article). You could even learn subconsciously by playing the audio while you are sleeping! If you are planning to listen a lot, you could try using a bone conduction headphone, or a standard speaker instead of an earphone.

Listen on Google Assistant through Extra Audio:
https://assistant.google.com/services/invoke/uid/0000001a130b3f91
Other Wikipedia audio articles at:
https://www.youtube.com/results?search_query=wikipedia+tts
Upload your own Wikipedia articles through:
https://github.com/nodef/wikipedia-tts
Speaking Rate: 0.8471739845034739
Voice name: en-US-Wavenet-F


"I cannot teach anybody anything, I can only make them think."
- Socrates


SUMMARY
=======
Biotechnology risk is a form of existential risk that could come from biological sources, such as genetically engineered biological agents. These can come either intentionally (in the form of bioterrorism/biological weapons) or unintentionally (through the accidental release of engineerer viruses). A chapter in biotechnology and biosecurity was published in Nick Bostrom's Global Catastrophic Risks, which covered risks such as viral agents. Since then, new technologies like CRISPR and gene drives have been introduced.
While the ability to deliberately engineer pathogens has been constrained to high-end labs run by top researchers, the technology to achieve this (and other astonishing feats of bioengineering) is rapidly becoming cheaper and more widespread. Such examples include the diminishing cost of sequencing the human genome (from $10M USD to $1000), the accumulation of large datasets of genetic information, the discovery of gene drives, and the discovery of CRISPR.